IREB2 and renal carcinoma: Here, we report a novel founding that low ACO1 and IREB2 contents in renal cancer are linked to the decreased invasion of B cells, neutrophils, CD4+ T cells, dendritic cells, and CD8+ T cells, along with macrophages (Figure 7).